Literature DB >> 12065407

INK4a-deficient human diploid fibroblasts are resistant to RAS-induced senescence.

Sharon Brookes1, Janice Rowe, Margarida Ruas, Susana Llanos, Paula A Clark, Martine Lomax, Marion C James, Radost Vatcheva, Stewart Bates, Karen H Vousden, David Parry, Nelleke Gruis, Nico Smit, Wilma Bergman, Gordon Peters.   

Abstract

The CDKN2A tumour suppressor locus encodes two distinct proteins, p16(INK4a) and p14(ARF), both of which have been implicated in replicative senescence, the state of permanent growth arrest provoked in somatic cells by aberrant proliferative signals or by cumulative population doublings in culture. Here we describe primary fibroblasts from a member of a melanoma-prone family who is homozygous for an intragenic deletion in CDKN2A. Analyses of the resultant gene products imply that the cells are p16(INK4a) deficient but express physiologically relevant levels of a frameshift protein that retains the known functions of p14(ARF). Although they have a finite lifespan, the cells are resistant to arrest by oncogenic RAS. Indeed, ectopic expression of RAS and telomerase (hTERT) results in outgrowth of anchorage-independent colonies that have essentially diploid karyotypes and functional p53. We find that in human fibroblasts, ARF is not induced demonstrably by RAS, pointing to significant differences between the proliferative barriers implemented by the CDKN2A locus in different cell types or species.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12065407      PMCID: PMC126048          DOI: 10.1093/emboj/cdf289

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  52 in total

Review 1.  Regulation of p53 stability.

Authors:  M Ashcroft; K H Vousden
Journal:  Oncogene       Date:  1999-12-13       Impact factor: 9.867

2.  PML regulates p53 acetylation and premature senescence induced by oncogenic Ras.

Authors:  M Pearson; R Carbone; C Sebastiani; M Cioce; M Fagioli; S Saito; Y Higashimoto; E Appella; S Minucci; P P Pandolfi; P G Pelicci
Journal:  Nature       Date:  2000-07-13       Impact factor: 49.962

3.  PML is induced by oncogenic ras and promotes premature senescence.

Authors:  G Ferbeyre; E de Stanchina; E Querido; N Baptiste; C Prives; S W Lowe
Journal:  Genes Dev       Date:  2000-08-15       Impact factor: 11.361

Review 4.  Telomere dynamics in cancer progression and prevention: fundamental differences in human and mouse telomere biology.

Authors:  W E Wright; J W Shay
Journal:  Nat Med       Date:  2000-08       Impact factor: 53.440

5.  An N-terminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivo.

Authors:  C A Midgley; J M Desterro; M K Saville; S Howard; A Sparks; R T Hay; D P Lane
Journal:  Oncogene       Date:  2000-05-04       Impact factor: 9.867

6.  Two arginine rich domains in the p14ARF tumour suppressor mediate nucleolar localization.

Authors:  H Rizos; A P Darmanian; G J Mann; R F Kefford
Journal:  Oncogene       Date:  2000-06-15       Impact factor: 9.867

7.  Contribution of two independent MDM2-binding domains in p14(ARF) to p53 stabilization.

Authors:  M A Lohrum; M Ashcroft; M H Kubbutat; K H Vousden
Journal:  Curr Biol       Date:  2000-05-04       Impact factor: 10.834

8.  Opposing effects of Ras on p53: transcriptional activation of mdm2 and induction of p19ARF.

Authors:  S Ries; C Biederer; D Woods; O Shifman; S Shirasawa; T Sasazuki; M McMahon; M Oren; F McCormick
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

9.  Oncogenic Ras induces p19ARF and growth arrest in mouse embryo fibroblasts lacking p21Cip1 and p27Kip1 without activating cyclin D-dependent kinases.

Authors:  A Groth; J D Weber; B M Willumsen; C J Sherr; M F Roussel
Journal:  J Biol Chem       Date:  2000-09-01       Impact factor: 5.157

10.  Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization.

Authors:  F Zindy; C M Eischen; D H Randle; T Kamijo; J L Cleveland; C J Sherr; M F Roussel
Journal:  Genes Dev       Date:  1998-08-01       Impact factor: 11.361

View more
  71 in total

Review 1.  Cellular senescence in cancer treatment: friend or foe?

Authors:  Pascal Kahlem; Bernd Dörken; Clemens A Schmitt
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

2.  Cellular senescence requires CDK5 repression of Rac1 activity.

Authors:  Kamilah Alexander; Hai-Su Yang; Philip W Hinds
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

Review 3.  Epigenetic control of aging.

Authors:  Ursula Muñoz-Najar; John M Sedivy
Journal:  Antioxid Redox Signal       Date:  2010-11-22       Impact factor: 8.401

4.  Multiple roles of cyclin-dependent kinase 4/6 inhibitors in cancer therapy.

Authors:  Patrick J Roberts; John E Bisi; Jay C Strum; Austin J Combest; David B Darr; Jerry E Usary; William C Zamboni; Kwok-Kin Wong; Charles M Perou; Norman E Sharpless
Journal:  J Natl Cancer Inst       Date:  2012-02-01       Impact factor: 13.506

Review 5.  Views from within and beyond: narratives of cardiac contractile dysfunction under senescence.

Authors:  Xiaoping Yang; Nair Sreejayan; Jun Ren
Journal:  Endocrine       Date:  2005-03       Impact factor: 3.633

6.  Ndy1/KDM2B immortalizes mouse embryonic fibroblasts by repressing the Ink4a/Arf locus.

Authors:  Alexandros Tzatsos; Raymond Pfau; Sotirios C Kampranis; Philip N Tsichlis
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-06       Impact factor: 11.205

Review 7.  p53--a Jack of all trades but master of none.

Authors:  Melissa R Junttila; Gerard I Evan
Journal:  Nat Rev Cancer       Date:  2009-09-24       Impact factor: 60.716

Review 8.  Mechanisms of Dysfunction in the Aging Vasculature and Role in Age-Related Disease.

Authors:  Anthony J Donato; Daniel R Machin; Lisa A Lesniewski
Journal:  Circ Res       Date:  2018-09-14       Impact factor: 17.367

9.  Circular RNAs are abundant, conserved, and associated with ALU repeats.

Authors:  William R Jeck; Jessica A Sorrentino; Kai Wang; Michael K Slevin; Christin E Burd; Jinze Liu; William F Marzluff; Norman E Sharpless
Journal:  RNA       Date:  2012-12-18       Impact factor: 4.942

10.  Low-penetrant RB allele in small-cell cancer shows geldanamycin instability and discordant expression with mutant ras.

Authors:  Yoonsoo Park; Akihito Kubo; Takefumi Komiya; Amy Coxon; Kristin Beebe; Len Neckers; Paul S Meltzer; Frederic J Kaye
Journal:  Cell Cycle       Date:  2008-05-30       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.